Richard Bernstein Advisors’s Gilead Sciences GILD Stock Holding History

Richard Bernstein Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,121	Closed	-$2.59M	–	241
2025 Q4	$2.59M	Sell	21,121 -2,327	-10%	-$283K	0.08%	46
2025 Q3	$2.6M	Sell	23,448 -26,942	-53%	-$3.06M	0.07%	60
2025 Q2	$5.59M	Buy	50,390 +22,805	+83%	+$2.43M	0.14%	56
2025 Q1	$3.09M	Sell	27,585 -1,140	-4%	-$118K	0.07%	143
2024 Q4	$2.65M	Sell	28,725 -5,653	-16%	-$509K	0.06%	180
2024 Q3	$2.88M	Hold	34,378	–	–	0.06%	173
2024 Q2	$2.36M	Hold	34,378	–	–	0.05%	189
2024 Q1	$2.52M	Hold	34,378	–	–	0.05%	189
2023 Q4	$2.78M	Buy	34,378 +19	+0.1%	+$1.48K	0.06%	154
2023 Q3	$2.57M	Hold	34,359	–	–	0.06%	163
2023 Q2	$2.65M	Hold	34,359	–	–	0.06%	127
2023 Q1	$2.85M	Hold	34,359	–	–	0.06%	129
2022 Q4	$2.95M	Hold	34,359	–	–	0.07%	126
2022 Q3	$2.12M	Hold	34,359	–	–	0.05%	156
2022 Q2	$2.12M	Hold	34,359	–	–	0.05%	168
2022 Q1	$2.04M	Hold	34,359	–	–	0.04%	189
2021 Q4	$2.49M	Hold	34,359	–	–	0.05%	188
2021 Q3	$2.4M	Buy	34,359 +2,024	+6%	+$142K	0.05%	192
2021 Q2	$2.23M	Hold	32,335	–	–	0.05%	193
2021 Q1	$2.09M	Hold	32,335	–	–	0.05%	197
2020 Q4	$1.88M	Hold	32,335	–	–	0.05%	208
2020 Q3	$2.04M	Hold	32,335	–	–	0.06%	159
2020 Q2	$2.49M	Sell	32,335 -6,743	-17%	-$517K	0.08%	144
2020 Q1	$2.92M	Sell	39,078 -14,516	-27%	-$1M	0.1%	114
2019 Q4	$3.48M	Hold	53,594	–	–	0.11%	136
2019 Q3	$3.4M	Hold	53,594	–	–	0.11%	139
2019 Q2	$3.62M	Hold	53,594	–	–	0.12%	129
2019 Q1	$3.48M	Hold	53,594	–	–	0.11%	152
2018 Q4	$3.35M	Hold	53,594	–	–	0.12%	164
2018 Q3	$4.14M	Buy	+53,594	New	+$4.05M	0.12%	183
2018 Q1	–	Sell	-50	Closed	-$4K	–	333
2017 Q4	$4K	Buy	+50	New	+$3.8K	﹤0.01%	320
2016 Q1	–	Sell	-55,533	Closed	-$5.62M	–	253
2015 Q4	$5.62M	Hold	55,533	–	–	0.72%	50
2015 Q3	$5.45M	Hold	55,533	–	–	0.75%	46
2015 Q2	$6.5M	Buy	55,533 +6,187	+13%	+$676K	0.79%	33
2015 Q1	$4.84M	Hold	49,346	–	–	0.63%	61
2014 Q4	$4.65M	Hold	49,346	–	–	0.48%	80
2014 Q3	$5.25M	Hold	49,346	–	–	0.55%	62
2014 Q2	$4.09M	Hold	49,346	–	–	0.48%	88
2014 Q1	$3.5M	Buy	49,346 +21,120	+75%	+$1.66M	0.5%	77
2013 Q4	$2.12M	Buy	28,226 +2,776	+11%	+$193K	0.43%	75
2013 Q3	$1.6M	Hold	25,450	–	–	0.47%	62
2013 Q2	$1.3M	Buy	+25,450	New	+$1.33M	0.43%	72

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Richard Bernstein Advisors's GILD Position: Q1 2026 in Review

Richard Bernstein Advisors sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 21,121 shares — an estimated $2.59M sold.

Richard Bernstein Advisors first reported a position in GILD in Q2 2013 and held it in 42 quarters. The position peaked at $6.5M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Richard Bernstein Advisors reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Richard Bernstein Advisors sold 21,121 Gilead Sciences shares in Q1 2026, an estimated $2.59M.
Richard Bernstein Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 42 quarters.
Richard Bernstein Advisors's Gilead Sciences position peaked at $6.5M in Q2 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Richard Bernstein Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.